EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update

Léna Royston iD, Genovefa A Papanicolaou, Dionysios Neofytos

Viruses · 2024

DOI: 10.3390/v16071085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Léna Royston und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University Hospital of Geneva, 1211 Geneva, Switzerland. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Antiviral Agents, Transplant Recipients, Drug Resistance, Viral. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the significant progress made, CMV infection is one of the most frequent infectious complications in transplant recipients. CMV infections that become refractory or resistant (R/R) to the available antiviral drugs constitute a clinical challenge and are associated with increased morbidity and mortality. Novel anti-CMV therapies have been recently developed and introduced in clinical practice, which may improve the treatment of these infections. In this review, we summarize the treatment options for R/R CMV infections in adult hematopoietic cell transplant and solid organ transplant recipients, with a special focus on newly available antiviral agents with anti-CMV activity, including maribavir and letermovir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsAntiviral AgentsTransplant RecipientsDrug Resistance, ViralCytomegalovirusHumansHematopoietic Stem Cell TransplantationOrgan TransplantationAcetatesDichlororibofuranosylbenzimidazoleQuinazolines

Stichwörter der Autor:innen

cytomegalovirus (CMV)letermovirmaribavirrefractory infectionresistant infectiontransplant recipients

Substanzen

Antiviral AgentsletermovirmaribavirAcetatesDichlororibofuranosylbenzimidazoleQuinazolines

Autor:innen und Institutionen

  • Division of Infectious Diseases, University Hospital of Geneva, 1211 Geneva, Switzerland.
  • Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.

ORCID-Profile: Léna Royston

Förderung

  • NCI NIH HHS

Zitieren

APA

Royston, L., Papanicolaou, G. A., & Neofytos, D. (2024). Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update. Viruses. https://doi.org/10.3390/v16071085

Vancouver

Royston L, Papanicolaou GA, Neofytos D. Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update. Viruses. 2024. doi:10.3390/v16071085

BibTeX
@article{Royston2024,
  author = {Royston, Léna and Papanicolaou, Genovefa A and Neofytos, Dionysios},
  title = {Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16071085}
}
Kostenlos starten →